Achmea Investment Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-221
| Closed | -$20K | – | 509 |
|
|
2023
Q2 | $20K | Hold |
221
| – | – | ﹤0.01% | 628 |
|
|
2023
Q1 | $22K | Hold |
221
| – | – | ﹤0.01% | 593 |
|
|
2022
Q4 | $21K | Hold |
221
| – | – | ﹤0.01% | 610 |
|
|
2022
Q3 | $19K | Hold |
221
| – | – | ﹤0.01% | 610 |
|
|
2022
Q2 | $19K | Hold |
221
| – | – | ﹤0.01% | 599 |
|
|
2022
Q1 | $17K | Hold |
221
| – | – | ﹤0.01% | 626 |
|
|
2021
Q4 | $19K | Hold |
221
| – | – | ﹤0.01% | 342 |
|
|
2021
Q3 | $17K | Buy |
+221
| New | +$17K | ﹤0.01% | 608 |
|
|
2020
Q3 | – | Sell |
-1,014
| Closed | -$125K | – | 490 |
|
|
2020
Q2 | $125K | Hold |
1,014
| – | – | ﹤0.01% | 269 |
|
|
2020
Q1 | $86K | Buy |
+1,014
| New | +$86K | ﹤0.01% | 232 |
|
|
2017
Q2 | – | Sell |
-2,554
| Closed | -$224K | – | 514 |
|
|
2017
Q1 | $224K | Buy |
+2,554
| New | +$224K | 0.01% | 513 |
|